AKT1 and Insulin resistance: More in detail, Sestrins increase AMPK activation, consequentially inhibiting mTORC1 activity, known to induce insulin resistance through the inhibition insulin receptor substrates and the consequent reduction of phosphoinositide-3-kinase (PI3K)/Akt signaling (Lee et al., 2013).